Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
27 hedge funds and large institutions have $1.72M invested in Intellipharmaceuticals International Inc. in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
66% more capital invested
Capital invested by funds: $1.03M → $1.72M (+$683K)
29% more funds holding
Funds holding: 21 → 27 (+6)
2% more call options, than puts
Call options by funds: $228K | Put options by funds: $223K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$182K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$98.2K |
| 3 |
HFS
HL Financial Services
Louisville,
Kentucky
|
+$92.2K |
| 4 |
ATC
Argent Trust Co
Nashville,
Tennessee
|
+$67.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$48.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atria Investments
Charlotte,
North Carolina
|
-$159K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$25.3K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$21.3K |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$21K |
| 5 |
Morgan Stanley
New York
|
-$1.96K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WB
26
Webster Bank
Waterbury,
Connecticut
| – | +$28 | +1 | New |
|
27
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$84 | +3 | +300% |
|
IPCI Hedge Fund Activity: Q4 2016 in Review
27 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q4 2016, worth a combined $1.72M — up 66% from $1.03M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IPCI positions and 2 closed out — a net gain of 6 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $182K. The largest seller was Atria Investments, exiting entirely with an estimated $159K sold.
- 27 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q4 2016, up from 21 in Q3 2016.
- Funds reported $1.72M of Intellipharmaceuticals International Inc. stock for Q4 2016, up 66% quarter-over-quarter.
- 8 funds opened new Intellipharmaceuticals International Inc. positions in Q4 2016 and 2 closed out, a net change of +6 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q4 2016 was Deutsche Bank, an estimated $182K added.
- The largest Intellipharmaceuticals International Inc. seller in Q4 2016 was Atria Investments, an estimated $159K sold.
Based on aggregated 13F filings for Q4 2016.